Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: A decision model analysis

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 427-435

  Feingold, B ^a,b   Webber, S A ^c   Bryce, C L ^d   Park, S Y ^b   Tomko, H E ^d   Comer, D M ^b   Mahle, W T ^e   Smith, K J ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alloantibody; cardiology; clinical decision making; crossmatch; health services and outcomes research; heart transplantation; organ allocation; organ procurement and allocation; pediatrics; sensitization

Indexed keywords

ALLOSENSITIZED HEART TRANSPLANTATION; ARTICLE; CHILD; DONOR; FEMALE; HEART TRANSPLANTATION; HUMAN; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MARKOV DECISION MODEL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; REGISTER; SURVIVAL; ALLOGRAFT; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; HOSPITAL ADMISSION; INFANT; MORTALITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TIME;

ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; MALE; MARKOV CHAINS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TIME FACTORS; TRANSPLANT RECIPIENTS; WAITING LISTS;

EID: 84921475134     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13071     Document Type: Article

References (21)

1. Feingold B, Park SY, Comer DM, Moore CG, Webber SA, Bryce CL., Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation. J Heart Lung Transplant 2013; 32: 56-62.
2. Feingold B, Bowman P, Zeevi A, et al. Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant 2007; 26: 565-571.
3. Holt DB, Lublin DM, Phelan DL, et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007; 26: 876-882.
4. Pollock-BarZiv SM, den Hollander N, Ngan B-Y, Kantor P, McCrindle B, Dipchand AI., Pediatric heart transplantation in human leukocyte antigen sensitized patients: Evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation 2007; 116: I172-I178.
5. Project Information: 1U01AI077867-01. National Institutes of Health Research Portfolio Online Reporting Tools website. Available from: http://projectreporter.nih.gov/project-info-description.cfm?aid=7451546&icde=11845357. Accessed April 7, 2014.
6. Richardson WS, Detsky AS., Users' guides to the medical literature: VII. How to use a clinical decision analysis. A. Are the results of the study valid ? JAMA 1995; 273: 1292-1295.
7. Lilford RJ, Pauker SG, Braunholtz DA, Chard J., Decision analysis and the implementation of research findings. Br Med J 1998; 317: 405-409.
8. Roberts MS, Tsevat J., Decision analysis. In, Aronson MD, (Ed.), UpToDate. Waltham, MA: Wolters Kluwar, 2014. Available at: http://pmtwww.uptodate.com/contents/decision-analysis. Accessed July 15, 2014.
9. Sonnenberg FA, Beck JR., Markov models in medical decision making: A practical guide. Med Decis Making 1993; 13: 322-338.
10. Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD., Model parameter estimation and uncertainty analysis: A report of the ISPOR-SMDM modeling good research practices task force working group-6. Med Decis Making 2012; 32: 722-732.
11. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ., Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985; 5: 157-177.
12. About data: OPTN database. OPTN: Organ Procurement Transplant Network. Available at: http://optn.transplant.hrsa.gov/data/about/OPTNDatabase.asp. Accessed April 1, 2014.
13. Pediatric Heart Transplant Study (PHTS): forms and manuals. Available at: http://www.uab.edu/medicine/phts/forms-and-manuals. Accessed April 17, 2014.
14. Girnita AL, Webber SA, Zeevi A., Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant. 2006; 10: 146-153.
15. Feingold B, Park SL, Comer DM, Bryce CL, Webber SA., Listing requirements for a prospective crossmatch in pediatric heart transplantation: Analysis of Organ Procurement and Transplantation Network data from 1996 to 2009. J Heart Lung Transplant 2012; 31: 1143-1144.
16. Patel R, Terasaki PI., Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735-739.
17. Mahle WT, Tresler MA, Edens E, et al. Allosensitization and outcomes in pediatric heart transplantation. J Heart Lung Transplant 2011; 30: 1221-1227.
18. Dayton JD, Kanter KR, Vincent RN, Mahle WT., Cost-effectiveness of pediatric heart transplantation. J Heart Lung Transplant 2006; 25: 409-415.
19. McDiarmid SV, Cherikh WS, Sweet SC., Preventable death: Children on the transplant waiting list. Am J Transplant 2008; 8: 2491-2495.
20. Drummond MF, Schulpher MJ, Torrance GW, O'Brien BJ, Stoddart GL., Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005.
21. Shechter SM, Bryce CL, Alagoz O, et al. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process. Med Decis Making 2005; 25: 199-209.